Contents Volume 7 · Issue 2 · 2013. Pages 147-273 14 articles
Molecular classification and molecular targeted therapy of cancer
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 147-149 doi:10.1007/s11684-013-0274-2
Progress on molecular biomarkers and classification of malignant gliomas
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 150-156 doi:10.1007/s11684-013-0267-1
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 157-171 doi:10.1007/s11684-013-0272-4
Present status and progress of neoadjuvant chemoradiotherapy for esophageal cancer
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 172-179 doi:10.1007/s11684-013-0268-0
Pharmacogenomics can improve antipsychotic treatment in schizophrenia
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 180-190 doi:10.1007/s11684-013-0249-3
From gut changes to type 2 diabetes remission after gastric bypass surgeries
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 191-200 doi:10.1007/s11684-013-0258-2
Metabolic hypertension: concept and practice
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 201-206 doi:10.1007/s11684-013-0264-4
Leptin signaling and leptin resistance
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 207-222 doi:10.1007/s11684-013-0263-5
The role of microRNAs in adipocyte differentiation
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 223-230 doi:10.1007/s11684-013-0252-8
Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 231-241 doi:10.1007/s11684-013-0253-7
Inflammation and liver tumorigenesis
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 242-254 doi:10.1007/s11684-013-0256-4
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 255-263 doi:10.1007/s11684-012-0227-1
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 264-269 doi:10.1007/s11684-013-0259-1
Frontiers of Medicine 2013, Volume 7, Issue 2, Pages 270-273 doi:10.1007/s11684-013-0261-7